Milen Minkov

St Anna Kinderspital
Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Central Nervous System Involvement in Children with Hemophagocytic Lymphohistiocytosis: an HLH-2004 Study Report.

Central Nervous System Involvement in Children with Hemophagocytic Lymphohistiocytosis: an HLH-2004 Study Report.

Journal: Blood advances

Published: March 20, 2026

Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis.

Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis.

Journal: Blood advances

Published: February 11, 2026

Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell Histiocytosis.

Disease Extent, Not Lesion Location, Determines Relapse Risk in Single-System Skeletal Langerhans Cell Histiocytosis.

Journal: Blood advances

Published: February 11, 2026

Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis.

Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis.

Journal: HemaSphere

Published: February 08, 2026

Isolated Epicardial Langerhans Cell Histiocytosis in a Neonate With Complete Spontaneous Regression.

Isolated Epicardial Langerhans Cell Histiocytosis in a Neonate With Complete Spontaneous Regression.

Journal: Pediatric blood & cancer

Published: February 01, 2026

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.

Journal: Blood cancer journal

Published: December 15, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Journal: Blood advances

Published: October 03, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Journal: Blood advances

Published: October 03, 2025

Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosis.

Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosis.

Journal: British journal of haematology

Published: September 01, 2025

Successful Treatment of Hepatoblastoma in a Child With Hypoplastic Left Heart Syndrome and Mosaic Trisomy 7.

Successful Treatment of Hepatoblastoma in a Child With Hypoplastic Left Heart Syndrome and Mosaic Trisomy 7.

Journal: Pediatric blood & cancer

Published: June 01, 2025

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts.

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts.

Journal: American journal of hematology

Published: May 30, 2025

Leukocyte Adhesion Defect Type I: Delayed Umbilical Cord Separation, a Surplus of Cells, and a Deficit of Defense.

Leukocyte Adhesion Defect Type I: Delayed Umbilical Cord Separation, a Surplus of Cells, and a Deficit of Defense.

Journal: The Journal of pediatrics

Published: May 26, 2025

Showing 1-12 of 66

Last Updated: 09/26/2026